Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

697 public trials 122 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

NCT01201811

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Changhua Christian Hospital Changhua, Taiwan
  • Chiayi Chang Gung Memorial Hospital Chiayi City, Taiwan
  • Buddhist Tzu Chi General Hospital-Hualien Tzu Chi Medical Center Hualien City, Taiwan
  • Kaohsiung Medical Hospital University Kaohsiung City, Taiwan
View Trial Details
Completed

Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes

NCT00102687

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Comprehensive Blood and Cancer Center, Research Department Bakersfield, California, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Cancer Center of Colorado Springs, The Oncology Clinic, PC Colorado Springs, Colorado, United States
  • Rocky Mountain Cancer Centers, LLP Denver, Colorado, United States
View all 31 locations
View Trial Details
Completed

Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.

NCT00812968

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Celgene Clinical Site Shimono, Tochigi, Japan
  • Celgene Clinical Site Shibuya-ku, Tokyo, Japan
  • Celgene Clinical Site Hiroshima, Japan
  • Celgene Clinical Site Kyoto, Japan
View Trial Details

Related conditions